XML 44 R27.htm IDEA: XBRL DOCUMENT
v3.24.4

Income Taxes | 12 Months Ended
--- | ---
Nov. 30, 2024
Income Tax Disclosure [Abstract] |
Income Taxes | Income Taxes The components of income before income taxes are as follows:
| Fiscal Year Ended
(in thousands) | November 30, 2024 |  | November 30, 2023 |  | November 30, 2022
U.S. | $ | 73,746 |  |  | $ | 70,659 |  |  | $ | 103,917 |
Foreign | 20,518 |  |  | 8,998 |  |  | 13,338 |
Total | $ | 94,264 |  |  | $ | 79,657 |  |  | $ | 117,255 |
The provision for income taxes is comprised of the following:
| Fiscal Year Ended
(in thousands) | November 30, 2024 |  | November 30, 2023 |  | November 30, 2022
Current: |  |  |  |  |
Federal | $ | 23,768 |  |  | $ | 28,905 |  |  | $ | 20,118 |
State | 4,635 |  |  | 4,373 |  |  | 5,039 |
Foreign | 5,173 |  |  | 4,823 |  |  | 4,631 |
Total current | 33,576 |  |  | 38,101 |  |  | 29,788 |
Deferred |  |  |  |  |
Federal | (7,868) |  |  | (22,763) |  |  | (4,683) |
State | (163) |  |  | (1,592) |  |  | (1,537) |
Foreign | 281 |  |  | (4,286) |  |  | (1,382) |
Total deferred | (7,750) |  |  | (28,641) |  |  | (7,602) |
Total | $ | 25,826 |  |  | $ | 9,460 |  |  | $ | 22,186 |
A reconciliation of the income taxes incurred at the U.S. federal statutory rate compared to the effective tax rate is as follows:
| Fiscal Year Ended
(in thousands) | November 30, 2024 |  | November 30, 2023 |  | November 30, 2022
Tax at U.S. federal statutory rate | $ | 19,795 |  |  | $ | 16,728 |  |  | $ | 24,624 |
Foreign rate differences | (728) |  |  | (644) |  |  | 475 |
Effects of foreign operations included in U.S. federal provision | 1,158 |  |  | 447 |  |  | 401 |
State income taxes, net | 1,480 |  |  | 1,814 |  |  | 2,424 |
Research credits | (2,513) |  |  | (894) |  |  | (1,268) |
Nondeductible stock-based compensation | 2,625 |  |  | 2,498 |  |  | 2,725 |
Meals and entertainment | 155 |  |  | 162 |  |  | 185 |
Compensation subject to 162(m) | 1,028 |  |  | 928 |  |  | 878 |
Uncertain tax positions and tax settlements | (108) |  |  | (1,056) |  |  | (163) |
Net excess tax benefit from stock-based compensation plans | (1,419) |  |  | (2,058) |  |  | (266) |
Global intangible low tax inclusion | 797 |  |  | 244 |  |  | 17 |
Foreign derived intangible deduction | (10,218) |  |  | (8,297) |  |  | (7,769) |
Tax on unremitted earnings | 13,889 |  |  | — |  |  | — |
Other | (115) |  |  | (412) |  |  | (77) |
Total | $ | 25,826 |  |  | $ | 9,460 |  |  | $ | 22,186 |
The components of deferred tax assets and liabilities are as follows:
(in thousands) | November 30, 2024 |  | November 30, 2023
Deferred tax assets: |  |  |
Accounts receivable | $ | 163 |  |  | $ | 174 |
Accrued compensation | 6,919 |  |  | 5,101 |
Accrued liabilities and other | 5,638 |  |  | 2,511 |
Deferred revenue | 40,199 |  |  | 20,204 |
Stock-based compensation | 10,138 |  |  | 9,459 |
Original issue discount | 12,055 |  |  | 5,135 |
Tax credit and loss carryforwards | 23,654 |  |  | 34,948 |
Operating lease liabilities | 6,335 |  |  | 3,208 |
Capitalized research and development | 36,006 |  |  | 20,814 |
Gross deferred tax assets | 141,107 |  |  | 101,554 |
Valuation allowance | (1,656) |  |  | (2,381) |
Total deferred tax assets | 139,451 |  |  | 99,173 |
Deferred tax liabilities: |  |  |
Goodwill | (27,646) |  |  | (25,454) |
Right-of-use lease assets | (5,200) |  |  | (2,196) |
Depreciation and amortization | (34,385) |  |  | (55,962) |
Unremitted earnings of foreign subsidiaries | (13,674) |  |  | — |
Prepaid expenses | (4,646) |  |  | (4,083) |
Total deferred tax liabilities | (85,551) |  |  | (87,695) |
Total | $ | 53,900 |  |  | $ | 11,478 |
Under provisions of the Tax Cuts and Jobs Act pursuant to Internal Revenue Code Section 174, beginning in fiscal year 2023 specific research and experimental ("R&E") expenditures are now required to be capitalized and amortized over five years for U.S. R&E and fifteen years for foreign R&E. The valuation allowance primarily applies to net operating loss carryforwards in foreign jurisdictions under conditions where realization is not more likely than not. The $0.9 million decrease in the valuation allowance during fiscal year 2024 primarily relates to losses in a foreign subsidiary that have expired prior to utilization. At November 30, 2024, we have federal and foreign net operating loss carryforwards of $35.2 million expiring on various dates through 2035 and $36.7 million that do not expire. In addition, we have state net operating loss carryforwards of $39.9 million expiring on various dates through 2043 and $15.6 million that do not expire. At November 30, 2024, we have state tax credit carryforwards of approximately $1.7 million expiring on various dates through 2039 and $3.2 million that may be carried forward indefinitely. In addition, we have federal tax credit carryforwards of approximately $5.9 million expiring on various dates through 2039. During the fourth quarter of 2024, we made the determination that a substantial portion of unremitted foreign earnings are no longer indefinitely reinvested. We made the decision as a direct result of changes in business needs related to the acquisition of ShareFile. As a result of the acquisition, the Company plans to utilize worldwide cash based on the needs of the parent entity. These amounts will be repatriated as needed. At November 30, 2024 we maintain a deferred tax liability of $13.7 million for the U.S. federal, state and foreign withholding taxes expected to be imposed upon the repatriation of unremitted foreign earnings that are not considered indefinitely reinvested. There is approximately $30.0 million of unremitted foreign earnings which are deemed to be indefinitely reinvested to support the working capital requirements of our foreign subsidiaries. A determination of the deferred tax liability on this amount is not practicable due to the complexities, variables and assumptions inherent in the hypothetical calculations. As of November 30, 2024, the total amount of unrecognized tax benefits was $5.2 million, of which $1.3 million was recorded in other noncurrent liabilities on the consolidated balance sheet and $3.9 million as a reduction of deferred tax assets, principally related to U.S net operating loss carry-forwards and federal and state research and development tax credits. A reconciliation of the balance of our unrecognized tax benefits is as follows:
| Fiscal Year Ended
(in thousands) | November 30, 2024 |  | November 30, 2023 |  | November 30, 2022
Balance, beginning of year | $ | 5,172 |  |  | $ | 5,276 |  |  | $ | 5,471 |
Tax positions related to a prior period | 416 |  |  | 19 |  |  | — |
Tax positions acquired | 311 |  |  | 423 |  |  | — |
Settlements with tax authorities | — |  |  | (367) |  |  | (45) |
Lapses due to expiration of the statute of limitations | (665) |  |  | (179) |  |  | (150) |
Balance, end of year | $ | 5,234 |  |  | $ | 5,172 |  |  | $ | 5,276 |
If recognized, all amounts of unrecognized tax benefits would affect the effective tax rate. We recognize interest and penalties related to uncertain tax positions as a component of our provision for income taxes. There was a minimal amount of estimated interest and penalties recorded in the provision for income taxes in the periods presented. We have accrued $0.3 million and $0.5 million of estimated interest and penalties at November 30, 2024 and 2023, respectively. We do not expect any significant changes to the amount of unrecognized tax benefits in the next twelve months. Our federal income tax returns have been examined or are closed by statute for all years prior to fiscal year 2021. Our state income tax returns have been examined or are closed by statute for all years prior to fiscal year 2020, and we are no longer subject to audit for those periods. Tax authorities for certain non-U.S. jurisdictions are also examining tax returns for various years dating back to 2016 and the Company does not expect the results of these examinations to be material to our consolidated balance sheets, cash flows or statements of income. With some exceptions, we are generally no longer subject to tax examinations in non-U.S. jurisdictions for years prior to fiscal year 2019.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration